However, limitations remain, including dose-escalationrelated GI intolerance, insufficient long-term safety, and currently unestablished relative potency compared with injectable GLP-1 RAs and multi-receptor peptide agonists [76]
[20] Without medical supervision, individuals with diabetes taking such medications face a meaningful risk of low blood sugar episodes
Oral GLP-1s offer significant weight loss benefits and blood sugar reduction, but not quite as much as the injections, Tenpas said
As many of their effects influence weight loss and management, the variety of formulations provide tailored treatment options for many individuals
With the exception of interactions of Glu1 and Asp3 with polar residues deep in the bundle, the first 9 residues of exendin-P5 do not form stable interactions with the TMD
Remind yourself that this side effect is well-documented, temporary in most cases, and not indicative of serious harm